March 4, 2021

TrakCel fuels growth and increased market access through strategic investment round

Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and Labcorp (NYSE: LH). These strategic investments enable further transformation of TrakCel’s cellular therapy orchestration solution, growth of its existing partner ecosystem, and continued global expansion. 

TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round

Please review the frequently asked questions below.
Not a patient? Visit Health Care Provider Help.


Still need help? Contact Us.
February 25, 2021

Celiac Disease Foundation advocates urge congress To continue support of celiac disease research funding

LOS ANGELES – (February 18, 2021) – Celiac disease afflicts millions of Americans, most of whom are undiagnosed, and is second only to end-stage renal disease in perceived burden by patients and caregivers. Despite these appalling facts, the federal government has never been a major funder of celiac disease research. As a direct consequence, celiac disease is the most prevalent genetic autoimmune disease with no FDA-approved treatments.

Celiac Disease Foundation Advocates Urge Congress To Continue Support of Celiac Disease Research Funding

February 24, 2021

Walgreens to make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit available over-the-counter at stores nationwide

DEERFIELD, Ill. & BURLINGTON, N.C., February 24, 2021 - As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp™ to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas.
February 22, 2021

Labcorp and EmblemHealth announce strategic collaboration to serve over 3 million members In New York communities

BURLINGTON, N.C., February 22, 2021— Labcorp (NYSE: LH), a leading global life sciences company, and EmblemHealth, one of the nation’s largest nonprofit health insurers, have entered into a strategic collaboration to provide laboratory testing services to the more than 3 million participants enrolled in EmblemHealth plans in New York and New Jersey. The preferred provider agreement allows EmblemHealth to offer its members best-in-class service and easier access to high-quality lab testing.